Approximately 90% of lipids in royal jelly are hydroxyl or dicarboxylic-free fatty acids that fight inflammation and oxidative cell damage, which could give the product anti-cancer effects. Breast, ovarian, and prostate cancers are associated with endogenous hormones such as estrogen. Royal jelly suppresses the production of many endogenous hormones, and it has structural similarities to estrogen. The anti-cancer effects appear to stem from this combination of factors.

This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.